Encorafenib
Encorafenib (trade name Braftovi) is a drug for the treatment of certain melanomas. it is a kinase inhibitor used to treat unresectable or metastatic melanoma with specific mutations. Reference standards of Encorafenib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object
(
[pname] => Encorafenib - API
[catalogue_number] => PA 05 1940000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[tag_name] =>
[weight] => 540.01
[form] => C22H27ClFN7O4S
[cas] => 1269440-17-6
[pslug] => 1269440-17-6-encorafenib-api-pa051940000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 05 1940000
Molecular Formula : C22H27ClFN7O4S
Molecular Weight : 540.01
stdClass Object
(
[pname] => Encorafenib R-Isomer
[catalogue_number] => PA 05 1941000
[category_ids] => ,75,76,78,70,82,
[chemical_name] =>
[tag_name] =>
[weight] => 540.01
[form] => C22H27ClFN7O4S
[cas] => 1269440-29-0
[pslug] => 1269440-29-0-encorafenib-r-isomer-pa051941000
[latest_product] => 0
[linkproducts] => 0
[offers_id] =>
[offers_name] =>
[offers_status] =>
[offers_start_date] =>
[offers_end_date] =>
[pageview] =>
[offers_slug] =>
[offers_product_id] =>
[offers_product_code] =>
[offers_master_id] =>
[offer_percentage] =>
[offers_product_main_cat] =>
)
Catalogue No.:PA 05 1941000
Molecular Formula : C22H27ClFN7O4S
Molecular Weight : 540.01